GRN and Parkinson disease: Compared to MAPT, GRN mutations are characterized by higher phenotypic variability, including FTD, amyotrophic lateral sclerosis (ALS), typical Parkinson’s disease (PD), and dementia with Lewy bodies (DLB) [103].